On June 9, 2020, the Board of Directors of Ardelyx, Inc. appointed Justin Renz as the Company’s Chief Accounting and Principal Financial Officer, replacing Keith Santorelli, the Company’s acting principal financial and accounting officer. Mr. Renz is a Certified Public Accountant with over 20 years of financial and accounting experience in the biopharmaceutical industry. Prior to joining the Company, from May 2017 to May 2020, Mr. Renz was the Chief Financial Officer of Correvio Pharma.